IP Library Assignment 062047/0915
Patent Assignment
Reel/Frame 062047/0915

Release of Security Interest

Recorded: 2022-12-02 Pages: 10
Assignor
WELLS FARGO BANK, N.A.
Executed: 2022-12-02
Assignees
PROGENICS PHARMACEUTICALS, INC.
331 TREBLE COVE ROAD, NORTH BILLERICA, MASSACHUSETTS, 01862
MOLECULAR INSIGHT PHARMACEUTICALS, INC.
331 TREBLE COVE ROAD, NORTH BILLERICA, MASSACHUSETTS, 01862
PSMA DEVELOPMENT COMPANY, LLC
331 TREBLE COVE ROAD, NORTH BILLERICA, MASSACHUSETTS, 01862
Covered Properties (48)
Technetium-Dipyridine Complexes, and Methods of Use Thereof
Patent: 7,381,399 →
Application: 10/386,403 →
Publication: US 2003/0235843
Psma Antibodies and Protein Multimers
Patent: 7,850,971 →
Application: 10/395,894 →
Publication: US 2004/0033229
Technetium-And Rhenium-Bis (Heteroaryl) Complexes, and Methods of Use Thereof
Patent: 8,685,369 →
Application: 10/589,405 →
Publication: US 2008/0025915
PSMA antibody-drug conjugates
Application: 11/471,457 →
Publication: US 2007/0160617
Compositions of Psma Antibodies
Patent: 8,114,965 →
Application: 11/983,372 →
Publication: US 2008/0286284
Technetium-Dipyridine Complexes, and Methods of Use Thereof
Patent: 7,875,258 →
Application: 12/124,736 →
Publication: US 2009/0023787
Technetium- and Rhenium-Bis(Heteroaryl) Complexes and Methods of Use Thereof
Patent: 8,562,945 →
Application: 12/631,312 →
Publication: US 2010/0183509
Technetium- and Rhenium-Bis(Heteroaryl) Complexes and Methods of Use Thereof for Inhibiting Psma
Patent: 8,211,401 →
Application: 12/631,337 →
Publication: US 2010/0178246
Process for Production of Heterodimers of Glutamic Acid
Patent: 8,465,725 →
Application: 12/815,637 →
Publication: US 2011/0008253
Psma Antibodies and Uses Thereof
Patent: 8,470,330 →
Application: 12/845,686 →
Publication: US 2011/0165081
Methods for Killing Psma-Expressing, Taxane-Resistant Cancer Cells
Patent: 9,242,012 →
Application: 13/030,105 →
Publication: US 2011/0250216
Heterodimers of Glutamic Acid
Patent: 9,309,193 →
Application: 13/271,549 →
Publication: US 2012/0269726
Heterodimers of Glutamic Acid
Patent: 8,487,129 →
Application: 13/294,677 →
Publication: US 2012/0208988
Radiolabeled Prostate Specific Membrane Antigen Inhibitors
Patent: 8,926,944 →
Application: 13/566,849 →
Publication: US 2013/0034494
Psma Antibodies and Uses Thereof
Patent: 9,695,248 →
Application: 13/608,337 →
Publication: US 2014/0286859
Antibodies for the Treatment of Clostridium Difficile-Associated Infection and Disease
Patent: 8,986,697 →
Application: 13/641,315 →
Publication: US 2013/0202618
Process for Production of Heterodimers of Glutamic Acid
Patent: 9,149,547 →
Application: 13/890,912 →
Publication: US 2014/0030188
Psma-Targeted Dendrimers
Patent: 9,687,572 →
Application: 13/991,812 →
Publication: US 2013/0336888
Technetium- and Rhenium-Bis(Heteroaryl) Complexes and Methods of Use Thereof
Patent: 8,840,865 →
Application: 14/041,643 →
Publication: US 2014/0179902
Triazine Based Radiopharmaceuticals and Radioimaging Agents
Patent: 9,447,121 →
Application: 14/152,864 →
Publication: US 2014/0255306
Combination Therapies with Psma Ligand Conjugates
Application: 14/277,367 →
Publication: US 2015/0110814
Technetium- and Rhenium-Bis(Heteroaryl) Complexes and Methods of Use Thereof
Patent: 8,962,799 →
Application: 14/446,220 →
Publication: US 2014/0341805
Radiolabeled Prostate Specific Membrane Antigen Inhibitors
Patent: 9,388,144 →
Application: 14/553,157 →
Publication: US 2015/0078998
Technetium- and Rhenium-Bis(Heteroaryl) Complexes and Methods of Use Thereof
Patent: 9,433,594 →
Application: 14/610,417 →
Publication: US 2016/0222036
Metal Complexes of Poly(Carboxyl)Amine-Containing Ligands Having an Affinity for Carbonic Anhydrase Ix
Patent: 9,422,251 →
Application: 14/820,953 →
Publication: US 2016/0009664
Organ Protection in Psma-Targeted Radionuclide Therapy of Prostate Cancer
Patent: 9,956,305 →
Application: 14/846,252 →
Publication: US 2016/0067361
Preparations of Meta-Iodobenzylguanidine and Precursors Thereof
Application: 14/921,898 →
Publication: US 2016/0115267
Heterodimers of Glutamic Acid
Application: 15/068,841 →
Publication: US 2016/0279235
Triazine Based Radiopharmaceuticals and Radioimaging Agents
Application: 15/233,096 →
Publication: US 2016/0346410
Heterodimers of Glutamic Acid
Patent: 9,878,980 →
Application: 15/337,867 →
Publication: US 2017/0044098
Triazine Based Radiopharmaceuticals and Radioimaging Agents
Application: 15/492,933 →
Publication: US 2017/0296683
Network for Medical Image Analysis, Decision Support System, and Related Graphical User Interface (Gui) Applications
Application: 15/794,220 →
Publication: US 2018/0144828
Heterodimers of Glutamic Acid
Application: 15/794,539 →
Publication: US 2018/0111895
Organ Protection in Psma-Targeted Radionuclide Therapy of Prostate Cancer
Application: 15/934,304 →
Publication: US 2018/0207299
Systems and Methods for Rapid Neural Network-Based Image Segmentation and Radiopharmaceutical Uptake Determination
Application: 16/003,006 →
Publication: US 2019/0209116
Heterodimers of Glutamic Acid
Application: 16/156,289 →
Publication: US 2019/0276393
Triazine Based Radiopharmaceuticals and Radioimaging Agents
Application: 16/231,153 →
Publication: US 2019/0134237
Network for Medical Image Analysis, Decision Support System, and Related Graphical User Interface (Gui) Applications
Application: 16/418,527 →
Publication: US 2020/0027559
Preparations of Meta-Iodobenzylguanidine and Precursors Thereof
Application: 16/437,061 →
Publication: US 2019/0367653
Network for Medical Image Analysis, Decision Support System, and Related Graphical User Interface (Gui) Applications
Application: 16/718,839 →
Publication: US 2020/0126666
Systems and Methods for Artificial Intelligence-Based Image Analysis for Cancer Assessment
Application: 16/734,609 →
Publication: US 2021/0093249
Systems and Methods for Automated and Interactive Analysis of Bone Scan Images for Detection of Metastases
Application: 16/856,120 →
Publication: US 2020/0337658
Organ Protection in Psma-Targeted Radionuclide Therapy of Prostate Cancer
Application: 16/860,925 →
Publication: US 2020/0254120
Heterodimers of Glutamic Acid
Application: 16/870,288 →
Publication: US 2021/0070695
Psma Antibody-Drug Conjugates
Application: 16/921,811 →
Publication: US 2021/0023094
Network for Medical Image Analysis, Decision Support System, and Related Graphical User Interface (Gui) Applications
Application: 16/938,488 →
Publication: US 2020/0357521
Systems and Methods for Rapid Neural Network-Based Image Segmentation and Radiopharmaceutical Uptake Determination
Application: 16/959,887 →
Publication: US 2020/0342600
Systems and Methods for Secure Cloud-Based Medical Image Upload and Processing
Application: 62/907,168 →
Related Assignments (5)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Oct 16, 2012
From: BABICH, JOHN W.; ZIMMERMAN, CRAIG; JOYAL, JOHN L.; LU, GENLIANG
To: MOLECULAR INSIGHT PHARMACEUTICALS
Reel/Frame 029139/0858 →
Release of Patent Security Interest Jan 18, 2013
From: NEXBANK, SSB (AS COLLATERAL AGENT)
To: MOLECULAR INSIGHT PHARMACEUTICALS, INC.
Reel/Frame 029660/0618 →
Assignment of Assignor's Interest Oct 22, 2015
From: MADDON, PAUL J.; DONOVAN, GERALD P.; OLSON, WILLIAM C.; SCHUELKE, NORBERT
To: PSMA DEVELOPMENT COMPANY, LLC
Reel/Frame 036922/0687 →
Security Agreement Aug 19, 2020
From: PROGENICS PHARMACEUTICALS, INC.; MOLECULAR INSIGHT PHARMACEUTICALS, INC.; PSMA DEVELOPMENT COMPANY LLC
To: WELLS FARGO BANK, N.A.
Reel/Frame 053538/0666 →
Security Interest Dec 2, 2022
From: LANTHEUS MEDICAL IMAGING, INC.; MOLECULAR INSIGHT PHARMACEUTICALS, INC.; PSMA DEVELOPMENT COMPANY, LLC; PROGENICS PHARMACEUTICALS, INC.
To: CITIZENS BANK, N.A.
Reel/Frame 062047/0960 →